Just what we need – another takeover rumor! Is GSK interested in Allergan? Or, perhaps, is Allergan interested in its own acquisitions?
Hospira cutting its workforce by 10%.
Dendreon finds a new way to endanger Provenge. This is a head-scratcher…
PLUS – Pfizer grabs its new Oncology Business Unit head from Cephalon.
Subscribe to the Impactiviti blog via e-mail
Subscribe to the Impactiviti blog via RSS
Connect with Steve Woodruff
Leave a Reply